Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Hormonal Balance is a specialized medical practice and healthcare entity focused on endocrinology, bioidentical hormone replacement therapy (BHRT), and regenerative medicine. Founded by Dr. Edwin Lee, the institute provides personalized clinical programs designed to restore hormonal equilibrium and address age-related physiological decline. Its service offerings include advanced peptide therapies, thyroid optimization, and nutritional medicine aimed at improving metabolic health and longevity. The institute is recognized within the functional medicine community for integrating traditional endocrine diagnostics with innovative therapeutic modalities to treat conditions such as menopause, andropause, and growth hormone deficiency. It operates primarily as a clinical center of excellence for hormonal health and wellness optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Hormonal Balance.